Xtant Medical Inc.

AMEX: XTNT · Real-Time Price · USD
0.65
-0.00 (-0.05%)
At close: Aug 15, 2025, 9:42 AM

Xtant Medical Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
127.77M 122.3M 117.27M 113.86M 110.94M 101.23M 91.3M 78.46M 67.91M 62.95M 57.97M 56.67M 55.98M 55.68M 55.26M 55.31M 55.55M 51.1M
Cost of Revenue
50.91M 51.14M 49.05M 44.53M 42.59M 39M 35.84M 31.83M 28.71M 27.84M 25.83M 25.14M 25.16M 23.72M 22.77M 21.53M 19.71M 18.23M
Gross Profit
76.86M 71.16M 68.22M 69.33M 68.36M 62.23M 55.47M 46.63M 39.2M 35.11M 32.14M 31.52M 30.82M 31.96M 32.49M 33.78M 35.84M 32.87M
Operating Income
28K -7.54M -12.07M -14M -13.61M -12.05M -10.16M -8.08M -6.59M -6.5M -6.75M -6.94M -6.49M -5.68M -3.85M -1.7M 504K 608K
Interest Income
n/a n/a n/a 16K 64K 64K 150K 165K 117K 117K 31K n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-4.27M -11.9M -16.26M -16.84M -4.95M -3.3M -1.04M 501K -8.77M -8.29M -8.41M -8.61M -8.04M -7.03M -4.85M -2.95M -2.51M -4.26M
Net Income
-4.58M -11.99M -16.45M -17.59M -3.33M -1.66M 660K 2.75M -8.83M -8.35M -8.48M -8.56M -8.01M -7.03M -4.85M -3.27M -2.83M -4.56M
Selling & General & Admin
74.6M 76.4M 77.9M 80.97M 79.82M 72.59M 64.29M 53.63M 44.97M 40.74M 37.98M 37.63M 36.44M 36.77M 35.48M 34.63M 34.57M 31.64M
Research & Development
2.23M 2.3M 2.39M 2.36M 2.15M 1.69M 1.34M 1.08M 815K 876K 915K 834K 867K 869K 870K 847K 761K 629K
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 1K 1K 1K
Operating Expenses
76.83M 78.7M 80.29M 83.33M 81.96M 74.28M 65.62M 54.71M 45.79M 41.61M 38.89M 38.47M 37.31M 37.64M 36.34M 35.48M 35.33M 32.26M
Interest Expense
4.38M 4.37M 4.16M 3.84M 3.4M 3.2M 2.94M 2.62M 2.3M 1.91M 1.69M 1.66M 1.55M 1.35M 995K 1.25M 3.02M 4.87M
Selling & Marketing Expenses
46.39M 47.96M 49.21M 49.11M 48.31M 43.84M 38.44M 32.69M 27.44M 24.36M 22.52M 22M 21.43M 21.38M 21.03M 21.12M 21.12M 19.43M
Cost & Expenses
127.74M 129.84M 129.34M 127.86M 124.55M 113.28M 101.46M 86.54M 74.5M 69.45M 64.72M 63.61M 62.47M 61.36M 59.12M 57.01M 55.04M 50.49M
Income Tax Expense
363K 144K 187K 743K 2.98M 2.96M 2.9M 2.35M 60K 60K 70K -46K -29K 1K 1K 325K 318K 298K
Shares Outstanding (Basic)
139.31M 143.56M 138.98M 135.1M 130.27M 130.2M 130.02M 128.14M 108.9M 108.89M 108.34M 93.28M 85.5M 87.19M 87.03M 86.76M 86.71M 81.25M
Shares Outstanding (Diluted)
148.57M 143.34M 138.98M 135.1M 130.27M 130.2M 130.02M 135.66M 108.9M 108.89M 108.34M 93.28M 87.31M 87.19M 87.03M 86.76M 86.71M 81.25M
EPS (Basic)
-0.03 -0.09 -0.12 -0.13 -0.02 -0.01 -0.00 0.01 -0.08 -0.08 -0.09 -0.1 -0.09 -0.08 -0.06 -0.06 -0.14 -0.32
EPS (Diluted)
-0.04 -0.09 -0.12 -0.13 -0.03 -0.02 -0.00 0.01 -0.08 -0.08 -0.09 -0.1 -0.09 -0.08 -0.06 -0.06 -0.14 -0.31
EBITDA
4.56M -3.25M -7.88M -8.91M 2.36M 3.6M 5.08M 5.6M -4.5M -4.9M -5.43M -5.68M -5.29M -4.44M -2.52M -237K 2.16M 2.38M
EBIT
99K -7.54M -12.1M -13M -1.55M -105K 1.9M 3.12M -6.47M -6.38M -6.72M -6.94M -6.49M -5.68M -3.85M -1.7M 504K 608K
Depreciation & Amortization
4.46M 4.29M 4.22M 4.09M 3.9M 3.71M 3.18M 2.48M 1.97M 1.49M 1.29M 1.26M 1.2M 1.24M 1.34M 1.47M 1.66M 1.77M